Oddly enough, I really can't get teary-eyed about the possible difficulties confronting shorts. Being long has been a nightmare all year thanks to shorts, leaks and Raj's unethical and possibly illegal actions. He has done us no favors, but sure has feathered his own nest.
We've been in a tough spot all year and still are. With an eps of +$1.35, and we still struggle to stay over $11? And, three FDA approved drugs on the market. IMO, there must be something dreadful we do not see.
If not, please tell me how another biotech with no drugs on the market and an eps of MINUS $1.01 closed Thursday at $16.77.
If the price was reversed, that would make a modicum of sense.
With each passing day, the image of the Titanic sinking into the Nevada desert becomes more vivid.